267 related articles for article (PubMed ID: 18212736)
1. Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins.
Wagner S; Carpentier I; Rogov V; Kreike M; Ikeda F; Löhr F; Wu CJ; Ashwell JD; Dötsch V; Dikic I; Beyaert R
Oncogene; 2008 Jun; 27(26):3739-45. PubMed ID: 18212736
[TBL] [Abstract][Full Text] [Related]
2. Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO.
Chiaravalli J; Fontan E; Fsihi H; Coic YM; Baleux F; Véron M; Agou F
Biochem Pharmacol; 2011 Nov; 82(9):1163-74. PubMed ID: 21803029
[TBL] [Abstract][Full Text] [Related]
3. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.
Verstrepen L; Carpentier I; Verhelst K; Beyaert R
Biochem Pharmacol; 2009 Jul; 78(2):105-14. PubMed ID: 19464428
[TBL] [Abstract][Full Text] [Related]
4. ABIN-1 negatively regulates NF-kappaB by inhibiting processing of the p105 precursor.
Cohen S; Ciechanover A; Kravtsova-Ivantsiv Y; Lapid D; Lahav-Baratz S
Biochem Biophys Res Commun; 2009 Nov; 389(2):205-10. PubMed ID: 19695220
[TBL] [Abstract][Full Text] [Related]
5. ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB.
Mauro C; Pacifico F; Lavorgna A; Mellone S; Iannetti A; Acquaviva R; Formisano S; Vito P; Leonardi A
J Biol Chem; 2006 Jul; 281(27):18482-8. PubMed ID: 16684768
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO.
Wyler E; Kaminska M; Coïc YM; Baleux F; Véron M; Agou F
Protein Sci; 2007 Sep; 16(9):2013-22. PubMed ID: 17766391
[TBL] [Abstract][Full Text] [Related]
7. DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding.
Grubisha O; Kaminska M; Duquerroy S; Fontan E; Cordier F; Haouz A; Raynal B; Chiaravalli J; Delepierre M; Israël A; Véron M; Agou F
J Mol Biol; 2010 Jan; 395(1):89-104. PubMed ID: 19854204
[TBL] [Abstract][Full Text] [Related]
8. The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kappaB inhibitor ABIN-2.
Hughes DP; Marron MB; Brindle NP
Circ Res; 2003 Apr; 92(6):630-6. PubMed ID: 12609966
[TBL] [Abstract][Full Text] [Related]
9. The inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKgamma to block activation of the transcription factor NF-kappaB and potentiate apoptosis.
Liu WK; Yen PF; Chien CY; Fann MJ; Su JY; Chou CK
Biochem J; 2004 Mar; 378(Pt 3):867-76. PubMed ID: 14653779
[TBL] [Abstract][Full Text] [Related]
10. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral gene transfer of ABIN-1 protects mice from TNF/galactosamine-induced acute liver failure and lethality.
Wullaert A; Wielockx B; Van Huffel S; Bogaert V; De Geest B; Papeleu P; Schotte P; El Bakkouri K; Heyninck K; Libert C; Beyaert R
Hepatology; 2005 Aug; 42(2):381-9. PubMed ID: 16025521
[TBL] [Abstract][Full Text] [Related]
12. The biology of A20-binding inhibitors of NF-kappaB activation (ABINs).
Verstrepen L; Carpentier I; Beyaert R
Adv Exp Med Biol; 2014; 809():13-31. PubMed ID: 25302363
[TBL] [Abstract][Full Text] [Related]
13. Protein-protein interactions involving IKKgamma (NEMO) that promote the activation of NF-kappaB.
Shifera AS
J Cell Physiol; 2010 Jun; 223(3):558-61. PubMed ID: 20301198
[TBL] [Abstract][Full Text] [Related]
14. Proteins that bind to IKKgamma (NEMO) and down-regulate the activation of NF-kappaB.
Shifera AS
Biochem Biophys Res Commun; 2010 Jun; 396(3):585-9. PubMed ID: 20457134
[TBL] [Abstract][Full Text] [Related]
15. Hsp70 inhibits lipopolysaccharide-induced NF-kappaB activation by interacting with TRAF6 and inhibiting its ubiquitination.
Chen H; Wu Y; Zhang Y; Jin L; Luo L; Xue B; Lu C; Zhang X; Yin Z
FEBS Lett; 2006 May; 580(13):3145-52. PubMed ID: 16697380
[TBL] [Abstract][Full Text] [Related]
16. ABINs inhibit EGF receptor-mediated NF-kappaB activation and growth of EGF receptor-overexpressing tumour cells.
Huang L; Verstrepen L; Heyninck K; Wullaert A; Revets H; De Baetselier P; Beyaert R
Oncogene; 2008 Oct; 27(47):6131-40. PubMed ID: 18622428
[TBL] [Abstract][Full Text] [Related]
17. Multiple redox regulation in NF-kappaB transcription factor activation.
Piette J; Piret B; Bonizzi G; Schoonbroodt S; Merville MP; Legrand-Poels S; Bours V
Biol Chem; 1997 Nov; 378(11):1237-45. PubMed ID: 9426183
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Canonical NF-κB Signaling by a Small Molecule Targeting NEMO-Ubiquitin Interaction.
Vincendeau M; Hadian K; Messias AC; Brenke JK; Halander J; Griesbach R; Greczmiel U; Bertossi A; Stehle R; Nagel D; Demski K; Velvarska H; Niessing D; Geerlof A; Sattler M; Krappmann D
Sci Rep; 2016 Jan; 6():18934. PubMed ID: 26740240
[TBL] [Abstract][Full Text] [Related]
19. The role of ubiquitin in NF-kappaB regulatory pathways.
Skaug B; Jiang X; Chen ZJ
Annu Rev Biochem; 2009; 78():769-96. PubMed ID: 19489733
[TBL] [Abstract][Full Text] [Related]
20. Use of fluorescence spectroscopy for quantitative investigations of ubiquitin interactions with the ubiquitin-binding domains of NEMO.
Dubosclard V; Fontan E; Agou F
Methods Mol Biol; 2015; 1280():321-37. PubMed ID: 25736758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
